These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 19141859)

  • 1. Activin-A attenuates several human natural killer cell functions.
    Robson NC; Wei H; McAlpine T; Kirkpatrick N; Cebon J; Maraskovsky E
    Blood; 2009 Apr; 113(14):3218-25. PubMed ID: 19141859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activin A regulates activities of peripheral blood natural killer cells of mouse in an autocrine and paracrine manner.
    Ma C; Liu Z; Shang S; Jiang L; Lv X; Qi Y; Cui X; Ge J
    Exp Cell Res; 2019 Jan; 374(1):114-121. PubMed ID: 30458178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of human cord blood CD34+ cell-derived NK cell cytotoxicity by dendritic cells.
    Yu Y; Hagihara M; Ando K; Gansuvd B; Matsuzawa H; Tsuchiya T; Ueda Y; Inoue H; Hotta T; Kato S
    J Immunol; 2001 Feb; 166(3):1590-600. PubMed ID: 11160200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activin A as a mediator of NK-dendritic cell functional interactions.
    Seeger P; Bosisio D; Parolini S; Badolato R; Gismondi A; Santoni A; Sozzani S
    J Immunol; 2014 Feb; 192(3):1241-8. PubMed ID: 24395917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activin-A: a novel dendritic cell-derived cytokine that potently attenuates CD40 ligand-specific cytokine and chemokine production.
    Robson NC; Phillips DJ; McAlpine T; Shin A; Svobodova S; Toy T; Pillay V; Kirkpatrick N; Zanker D; Wilson K; Helling I; Wei H; Chen W; Cebon J; Maraskovsky E
    Blood; 2008 Mar; 111(5):2733-43. PubMed ID: 18156495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Augmented anti-tumor activity of NK-92 cells expressing chimeric receptors of TGF-βR II and NKG2D.
    Wang Z; Guo L; Song Y; Zhang Y; Lin D; Hu B; Mei Y; Sandikin D; Liu H
    Cancer Immunol Immunother; 2017 Apr; 66(4):537-548. PubMed ID: 28184969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transpresentation of interleukin-15 by IL-15/IL-15Rα mRNA-engineered human dendritic cells boosts antitumoral natural killer cell activity.
    Van den Bergh J; Willemen Y; Lion E; Van Acker H; De Reu H; Anguille S; Goossens H; Berneman Z; Van Tendeloo V; Smits E
    Oncotarget; 2015 Dec; 6(42):44123-33. PubMed ID: 26675759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TGF-beta utilizes SMAD3 to inhibit CD16-mediated IFN-gamma production and antibody-dependent cellular cytotoxicity in human NK cells.
    Trotta R; Dal Col J; Yu J; Ciarlariello D; Thomas B; Zhang X; Allard J; Wei M; Mao H; Byrd JC; Perrotti D; Caligiuri MA
    J Immunol; 2008 Sep; 181(6):3784-92. PubMed ID: 18768831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic blockade of activin-A improves NK cell function and antitumor immunity.
    Rautela J; Dagley LF; de Oliveira CC; Schuster IS; Hediyeh-Zadeh S; Delconte RB; Cursons J; Hennessy R; Hutchinson DS; Harrison C; Kita B; Vivier E; Webb AI; Degli-Esposti MA; Davis MJ; Huntington ND; Souza-Fonseca-Guimaraes F
    Sci Signal; 2019 Aug; 12(596):. PubMed ID: 31455725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transforming growth factor-beta- and Activin-Smad signaling pathways are activated at distinct maturation stages of the thymopoeisis.
    Rosendahl A; Speletas M; Leandersson K; Ivars F; Sideras P
    Int Immunol; 2003 Dec; 15(12):1401-14. PubMed ID: 14645149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The TGF-β/SMAD pathway is an important mechanism for NK cell immune evasion in childhood B-acute lymphoblastic leukemia.
    Rouce RH; Shaim H; Sekine T; Weber G; Ballard B; Ku S; Barese C; Murali V; Wu MF; Liu H; Shpall EJ; Bollard CM; Rabin KR; Rezvani K
    Leukemia; 2016 Apr; 30(4):800-11. PubMed ID: 26621337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activin A, a Novel Chemokine, Induces Mouse NK Cell Migration via AKT and Calcium Signaling.
    Wang Y; Liu Z; Qi Y; Wu J; Liu B; Cui X
    Cells; 2024 Apr; 13(9):. PubMed ID: 38727264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammation-restraining effects of prostaglandin E2 on natural killer-dendritic cell (NK-DC) interaction are imprinted during DC maturation.
    Van Elssen CH; Vanderlocht J; Oth T; Senden-Gijsbers BL; Germeraad WT; Bos GM
    Blood; 2011 Sep; 118(9):2473-82. PubMed ID: 21715307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dendritic cell regulation of NK-cell responses involves lymphotoxin-α, IL-12, and TGF-β.
    Sarhan D; Palma M; Mao Y; Adamson L; Kiessling R; Mellstedt H; Österborg A; Lundqvist A
    Eur J Immunol; 2015 Jun; 45(6):1783-93. PubMed ID: 25773885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells.
    Ferlazzo G; Tsang ML; Moretta L; Melioli G; Steinman RM; Münz C
    J Exp Med; 2002 Feb; 195(3):343-51. PubMed ID: 11828009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activating immunity in the liver. II. IFN-beta attenuates NK cell-dependent liver injury triggered by liver NKT cell activation.
    Trobonjaca Z; Kröger A; Stober D; Leithäuser F; Möller P; Hauser H; Schirmbeck R; Reimann J
    J Immunol; 2002 Apr; 168(8):3763-70. PubMed ID: 11937527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of c-Myb in the regulation of natural killer cell activity.
    Shin HW; Lee YJ; Kim J
    Biochem Biophys Res Commun; 2018 Sep; 503(4):2807-2813. PubMed ID: 30103947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leptin modulates dose-dependently the metabolic and cytolytic activities of NK-92 cells.
    Lamas B; Goncalves-Mendes N; Nachat-Kappes R; Rossary A; Caldefie-Chezet F; Vasson MP; Farges MC
    J Cell Physiol; 2013 Jun; 228(6):1202-9. PubMed ID: 23129404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous immunoglobulins suppress T-cell priming by modulating the bidirectional interaction between dendritic cells and natural killer cells.
    Tha-In T; Metselaar HJ; Tilanus HW; Groothuismink ZM; Kuipers EJ; de Man RA; Kwekkeboom J
    Blood; 2007 Nov; 110(9):3253-62. PubMed ID: 17673603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cord blood natural killer cells expressing a dominant negative TGF-β receptor: Implications for adoptive immunotherapy for glioblastoma.
    Yvon ES; Burga R; Powell A; Cruz CR; Fernandes R; Barese C; Nguyen T; Abdel-Baki MS; Bollard CM
    Cytotherapy; 2017 Mar; 19(3):408-418. PubMed ID: 28109751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.